Phase 1 - Starting and Ramping Up (month 1 to 3) Dose: If one has had no prior GLP-1 therapy, they will be started on a very low dose of 0.25mg a week
Most BPC-157 safety data comes from animal research
There is no simple yes or no answer
We provide continuous support through: Personalized nutrition and hydration guidance Regular check-ins and dose adjustments Education on managing appetite and energy Compassionate, judgment-free accountability Our goal isnt just helping you lose belly fatits helping you feel confident, strong, and in control of your long-term health
Weight loss itself may also affect energy levels, which can be challenging for new mothers adjusting to infant care
The symposium also will review additional results from the trial, including blood pressure, lipids, A1C, and other key endpoints, as well as the tirzepatide safety profile